针对Stenotrophomonas maltophilia的新型细菌菌体的分离和表征

Wakana Yamashita1,2, Yuta Sato1,2, Matthew Imanaka1,2

  • 1Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, 162-8640, Japan.

Scientific reports
|August 13, 2025
PubMed
概括

研究人员分离了针对抗生素耐药性Stenotrophomonas maltophilia的新型细菌菌体. 这些菌体表现出强烈的性活性,缺乏有害基因,为治疗困难感染提供了有希望的替代方案.